Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TUBB1 | Q9H4B7 | 17/20 | 1.00 |
| ▸ | TUBB4A | P04350 | 7/20 | 1.00 |
| ▸ | TUBB | P07437 | 7/20 | 1.00 |
| ▸ | TUBA3C | P0DPH7 | 7/20 | 1.00 |
| ▸ | TUBA1B | P68363 | 7/20 | 1.00 |
| ▸ | TUBA4A | P68366 | 7/20 | 1.00 |
| ▸ | TUBB4B | P68371 | 7/20 | 1.00 |
| ▸ | TUBB3 | Q13509 | 7/20 | 1.00 |
| ▸ | TUBB2A | Q13885 | 7/20 | 1.00 |
| ▸ | TUBB8 | Q3ZCM7 | 7/20 | 1.00 |
| ▸ | TUBA3E | Q6PEY2 | 7/20 | 1.00 |
| ▸ | TUBA1A | Q71U36 | 7/20 | 1.00 |
| ▸ | TUBA1C | Q9BQE3 | 7/20 | 1.00 |
| ▸ | TUBB6 | Q9BUF5 | 7/20 | 1.00 |
| ▸ | TUBB2B | Q9BVA1 | 7/20 | 1.00 |
| ▸ | SLC22A2 | O15244 | 1/20 | 1.00 |
| ▸ | SLCO2B1 | O94956 | 1/20 | 1.00 |
| ▸ | ABCB1 | P08183 | 1/20 | 1.00 |
| ▸ | SLC22A6 | Q4U2R8 | 1/20 | 1.00 |
| ▸ | SLC22A8 | Q8TCC7 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Combretastatin A4 SCHEMBL18946 | 1.00 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL29355902 | 1.00 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL18945 | 1.00 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL29501750 | 1.00 | TUBB1 (1.00) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL4452799 | 0.98 | TUBB1 (0.97) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL6456251 | 0.95 | TUBB1 (0.91) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| SCHEMBL13813246 | 0.95 | TUBB1 (0.90) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL5073658 | 0.94 | TUBB1 (0.88) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL8188814 | 0.92 | TUBB1 (0.85) | TUBB1TUBB4ATUBBTUBA3CTUBA1B | |
| Combretastatin A4 SCHEMBL6905413 | 0.91 | TUBB1 (0.83) | TUBB1TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240315965-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2024-09-26 | — | — | US | claimed |
| WO-2022182527-A1 | COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS | Natural Extraction Systems, LLC (US) | 2022-09-01 | — | — | WO | claimed |
| CN-106336347-B | New method for synthesizing hydroxystilbenes | 中国科学院成都有机化学有限公司 | 2020-08-18 | — | — | CN | claimed |
| US-12630450-B1 | Somatic embryonic cell suspension for wastewater treatment | King Faisal University (SA) | 2026-05-19 | — | — | US | disclosed |
| US-20240355451-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | NESTLE SA (CH) | 2024-10-24 | — | — | US | disclosed |
| WO-2024176961-A1 | PROTEIN RECOGNIZING K-Ras GENE MUTATION CANCER | 国立研究開発法人理化学研究所 | 2024-08-29 | — | — | WO | disclosed |
| CN-117982683-B | Drug delivery system with reduction responsiveness and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-08-06 | — | — | CN | disclosed |
| EP-4391834-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2024-07-03 | — | — | EP | disclosed |
| CN-117982683-A | Drug delivery system with reduction responsiveness and preparation method and application thereof | 中国科学院苏州纳米技术与纳米仿生研究所 | 2024-05-07 | — | — | CN | disclosed |
| US-20230255989-A1 | GLYCAN COMPOSITIONS AND USES THEREOF | DSM NUTRITIONAL PRODUCTS LLC (US) | 2023-08-17 | — | — | US | disclosed |
| WO-2023025722-A1 | METHODS FOR IMPROVING GUT MICROBIOTA DIVERSITY | Société des Produits Nestlé S.A. (CH) | 2023-03-02 | — | — | WO | disclosed |
| US-20150359884-A1 | MULTI-PHOTON ISOMERISATION OF COMBRETASTATINS AND THEIR USE IN THERAPY | BISBY ROGER H (GB) | 2015-12-17 | — | — | US | disclosed |
| WO-2015108595-A1 | ANTI-TUMOR THERAPY | KHODAREV NIKOLAI (US) | 2015-07-23 | — | — | WO | disclosed |
| US-8853270-B2 | Substituted stilbenes and their reactions | UNIVERSITY OF SALFORD (GB) | 2014-10-07 | — | — | US | disclosed |
| US-20130023663-A1 | SUBSTITUTED STILBENES AND THEIR REACTIONS | HADFIELD JOHN ANTHONY (GB) | 2013-01-24 | — | — | US | disclosed |
| US-20070203217-A1 | SUBSTITUTED STILBENES AND THEIR REACTIONS | UNIVERSITEIT UTRECHT UU HOLDING B.V. (NL) | 2007-08-30 | — | — | US | disclosed |
| US-20070203217-A1 | SUBSTITUTED STILBENES AND THEIR REACTIONS | UNIVERSITEIT UTRECHT UU HOLDING B.V. (NL) | 2007-08-30 | — | — | US | disclosed |
| US-7220784-B2 | Substituted stilbenes and their reactions | CANCER RESEARCH VENTURES LIMITED (GB) | 2007-05-22 | — | — | US | disclosed |
| US-7220784-B2 | Substituted stilbenes and their reactions | CANCER RESEARCH VENTURES LIMITED (GB) | 2007-05-22 | — | — | US | disclosed |
| WO-1992016486-A1 | SUBSTITUTED DIPHENYLETHYLENES AND ANALOGUES OR DERIVATIVES THEREOF | ASTON MOLECULES LIMITED (GB) | 1992-10-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130023663-A1 | SUBSTITUTED STILBENES AND THEIR REACTIONS | BLVRB, BBOX1, SQLE | TUBB1 1121/4885TUBB4A 869/4885TUBB 1023/4885 |
| US-12630450-B1 | Somatic embryonic cell suspension for wastewater treatment | ALPG, PROX1, KIT | TUBB1 2383/4885TUBB4A 2035/4885TUBB 1587/4885 |
| US-20070203217-A1 | SUBSTITUTED STILBENES AND THEIR REACTIONS | CASP4, ATG4B, CTSB | TUBB1 1146/4885TUBB4A 568/4885TUBB 1056/4885 |
| US-20150359884-A1 | MULTI-PHOTON ISOMERISATION OF COMBRETASTATINS AND THEIR USE IN THERAPY | SLC5A6, FLT4, FOLR2 | TUBB1 867/4885TUBB4A 548/4885TUBB 705/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.